LOADING...

Institute of Translational Medicine and Innovative Drugs

Institute of Translational Medicine and Innovative Drugs


Director: Dr. Dongliang Ge, gedongliang@bioscikin.com

BioSciKin Co., Ltd


The Institute of Translational Medicine and Innovative Drugs(ITMID) was jointly founded in June 2013 by Simcere Pharmaceutical Co., Ltd. and Xu Zhuang Software Park. It now has a staff of 156. ITMID also has research equipment of RMB 145 million, including NMR spectrometer, HPLC-MS, Image Xpress Micro XLS, BD FACS Calibur, etc. ITMID provided technical services for more than 60 enterprises and obtained R&D fund of RMB 40 million.

R&D fields

Research of tumor biological markers

Research and development of innovative drugs targeting tumor

Tumor immunotherapy drug development

Key technologies research of translational medicine and development

Discovery and marketing of new biomarkers, companion diagnostics, medical wearables and sensors or e-health solutions related to precision diagnosis and treatment

Dr. Dongliang Ge

No. 18-699, Xuanwu Road, Nanjing

+86-25-85566666

gedongliang@bioscikin.com

http://www.bioscikin.com

Contact us


  • Address : No. 699 Xuanwu Avenue, Nanjing, China
  • Telephone : +86-25-83455189
  • Fax : +86-25-83455109
  • Email : rdd@jitri.org
Scroll to Top